Basel Medical Group Ltd Ordinary Shares Capital Reinvestment Ratio
Basel Medical Group Ltd Ordinary Shares capital reinvestment ratio. Basel Medical Group Ltd Ordinary Shares (BMGL) has a Capital Reinvestment Ratio of 0.00x as of June 2024, meaning it reinvests 0% of its operating cash flow ($2.51 Million) in capital expenditures ($7.92K). Check Basel Medical Group Ltd Ordinary Shares (BMGL) reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Basel Medical Group Ltd Ordinary Shares (2022–2024)
Capital reinvestment ratio of Basel Medical Group Ltd Ordinary Shares from 2022 to 2024. This chart tracks Basel Medical Group Ltd Ordinary Shares's Capital Reinvestment Ratio across 3 annual periods. Also explore BMGL shareholders equity momentum to track the company's year-over-year net asset growth rate.
Basel Medical Group Ltd Ordinary Shares Capital Reinvestment Ratio by Year (2022–2024)
Basel Medical Group Ltd Ordinary Shares capital reinvestment ratio by year from 2022 to 2024. For the full cash flow conversion analysis, see how efficiently does Basel Medical Group Ltd Ordinary Shares generate cash.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.00x | $2.51 Million | $7.92K | ▲ +33.2% |
| 2023 | 0.00x | $2.60 Million | $6.16K | ▼ -92.5% |
| 2022 | 0.03x | $2.79 Million | $88.50K | — |